Applications including "pharmaceutical"

LT201 - Analysis of nitrosoamines by LC-MS / MS, HPLC using InertSustain AQ-C18 -Comparison with PFP column- -

LC Technical Note InertSustain AQ-C18 InertSustain PFP
GA113 - Residual solvents in pharmaceuticals -

GC InertSearch InertCap Pure-WAX
LB902 - Analysis of Saxagliptin -

LC InertSearch InertSustain C18
LB901 - Analysis of Saxagliptin -

LC InertSearch InertSustain C18
LB900 - Analysis of Fesoterodine Fumarate -

LC InertSearch InertSustain C8
LB899 - Analysis of Fesoterodine Fumarate -

LC InertSearch InertSustainSwift C18
GA351 - Analysis of Dextran 40 -

GC InertSearch InertCap 1
GA350 - Analysis of Acrylic Acid and Methyl Methacrylate -

GC InertSearch InertCap 1
LB896 - Analysis of Triptorelin Pamoate -

LC InertSearch InertSustain C18
LB895 - Analysis of Venlafaxine hydrochloride -

LC InertSearch InertSustainSwift C8
LB894 - Analysis of Ursodiol -

LC InertSearch Inertsil WP300
LB891 - Analysis of Saxagliptin -

LC InertSearch InertSustain C18 HP
LB890 - Analysis of Saxagliptin -

LC InertSearch InertSustain C18 HP
LB889 - Analysis of Propyl gallate -

LC InertSearch Inertsil WP300
LB888 - Analysis of Propyl gallate -

LC InertSearch Inertsil WP300
LB887 - Analysis of Propyl gallate -

LC InertSearch Inertsil ODS-4
LB885 - Analysis of Voriconazole -

LC InertSearch InertSustain C18
LB884 - Analysis of Voriconazole -

LC InertSearch InertSustain C18
LB883 - Analysis of Paclitaxel -

LC InertSearch InertSustain PFP
LB882 - Analysis of Paracetamol and Mefenamic acid -

LC InertSearch InertSustain C18
LB881 - Analysis of Paracetamol and Mefenamic acid -

LC InertSearch Inertsil ODS-3
LB880 - Analysis of Paracetamol and Mefenamic acid -

LC InertSearch InertSustain C18
LB879 - Analysis of Paracetamol and Mefenamic acid -

LC InertSearch Inertsil ODS-3
LB878 - Analysis of Mefenamic acid -

LC InertSearch InertSustain C18
LB877 - Analysis of Mefenamic acid -

LC InertSearch Inertsil ODS-3
LB876 - Analysis of Cefoxitin -

LC InertSearch InertSustain C18
LB875 - Analysis of Levofloxacin -

LC InertSearch Inertsil ODS-3
LB874 - Analysis of Captopril and Captopril Disulfide -

LC InertSearch InertSustain AQ-C18
LB873 - Tacrolimus Extended-Release Capsules -

LC InertSearch InertSustain AQ-C18
LB872 - Analysis of Febuxostat -

LC InertSearch InertSustain Phenyl
LB871 - Analysis of Febuxostat -

LC InertSearch InertSustain Phenyl
LB870 - Analysis of Febuxostat -

LC InertSearch InertSustain Phenyl
LB867 - Analysis of Febuxostat -

LC InertSearch InertSustain C18
LB849 - Analysis of Tolvaptan (Under the Condition of the draft for the Japanese Pharmacopoeia 18th SupplementII) -

LC InertSearch Inertsil ODS-4
LB848 - Analysis of Tolvaptan (Under the Condition of the draft for the Japanese Pharmacopoeia 18th SupplementII) -

LC InertSearch Inertsil ODS-4
LB837 - Analysis of Nonsteroidal anti-inflammatory drug -

LC InertSearch InertSustain C30
LB827 - Analysis of Clobetasone butyrate standard -

LC InertSearch InertSustainSwift C18
LB823 - Analysis of Glycyrrhiza -

LC InertSearch Inertsil ODS-3
LB816 - Analysis of Zoledronic acid -

LC InertSearch InertSustainSwift C18
LB815 - Analysis of Riboflavin (Vitamin B2) and its metabolites -

LC InertSearch InertSustainSwift C18
LB814 - Analysis of Coenzyme A (CoA) -

LC InertSearch InertSustain AQ-C18
LB806 - Analysis of Ampicillin and Sulbactam (Under the Condition of the Japanese Pharmacopoeia 18th , Ampicillin Sodium and Sulbactam Sodium for Injection) -

LC InertSearch Inertsil ODS-HL
LB804 - Analysis of Metformin -

LC InertSearch Inertsil CX
LB803 - Simultaneous analysis of Amino acids derivatized with 4-fluoro-7-nitro-2,1,3-benzoxadiazole (NBD-F) -

LC InertSearch InertSustain C30
LB789 - Analysis of Oligonucleotides -

LC InertSearch InertSustain AX-C18
LB788 - Analysis of Oligonucleotides -

LC InertSearch InertSustain AX-C18
LB787 - Analysis of Oligonucleotides -

LC InertSearch InertSustain AX-C18
LB786 - Analysis of Oligonucleotides -

LC InertSearch InertSustain AX-C18
LB779 - Analysis of Coenzyme A (CoA) -

LC InertSearch InertSustain AX-C18
LB778 - Analysis of Coenzyme A (CoA) -

LC InertSearch InertSustain AX-C18
LB773 - Analysis of Nicotinamide adenine dinucleotide and Nicotinamide adenine dinucleotide phosphate (NAD+, NADH, NADP+, NADPH) -

LC InertSearch InertSustain AX-C18
LB772 - Analysis of Nicotinamide adenine dinucleotide (NADH, NAD+) -

LC InertSearch InertSustain AX-C18
LB771 - Analysis of Nucleoside and Nucleic acid base -

LC InertSearch InertSustain AX-C18
LB769 - Analysis of Thiamine and Thiamine pyrophosphate -

LC InertSearch InertSustain AX-C18
LB768 - Analysis of Low molecular weight Hyaluronic acid -

LC InertSearch InertSustain AX-C18
LB767 - Analysis of Chondroitin Sulfate -

LC InertSearch InertSustain AX-C18
LB762 - Analysis of L-Cysteic acid -

LC InertSearch InertSustain AX-C18
LB761 - Analysis of Doripenem (Under the Condition of the Japanese Pharmacopoeia 18th, Doripenem Hydrate) -

LC InertSearch Inertsil ODS-4
LB760 - Analysis of Doripenem (Under the Condition of the Japanese Pharmacopoeia 18th, Doripenem Hydrate) -

LC InertSearch InertSustain C18
LB759 - Analysis of Doripenem (Under the Condition of the Japanese Pharmacopoeia 18th, Doripenem Hydrate) -

LC InertSearch InertSustain AX-C18
LB758 - Analysis of Doripenem (Under the Condition of the Japanese Pharmacopoeia 18th, Doripenem Hydrate) -

LC InertSearch InertSustain C18
LB757 - Analysis of Fenofibrate (Under the Condition of the Japanese Pharmacopoeia 18th) -

LC InertSearch Inertsil ODS-4
LB756 - Analysis of Fenofibrate (Under the Condition of the Japanese Pharmacopoeia 18th) -

LC InertSearch Inertsil ODS-4
LB755 - Analysis of Oxaliplatin (Under the Condition of the draft for the Japanese Pharmacopoeia18th supplement II) -

LC InertSearch InertSustainSwift C18
LB754 - Analysis of Saccharin (Under the Condition of the Japanese Pharmacopoeia 18th, Saccharin Sodium Hydrate) -

LC InertSearch Inertsil WP300 C18
LB740 - Analysis of Acetaminophen -

LC InertSearch Inertsil ODS-3
LB739 - Analysis of Acetaminophen -

LC InertSearch Inertsil ODS-3
LB738 - Analysis of Remdesivir -

LC InertSearch InertSustain AX-C18
LB737 - Analysis of Favipiravir -

LC InertSearch InertSustain AX-C18
LB736 - Analysis of Antidepressants -

LC InertSearch InertSustain AX-C18
LB735 - Analysis of Antihistamines -

LC InertSearch InertSustain AX-C18
LB733 - Analysis of Water-soluble Vitamins -

LC InertSearch InertSustain AX-C18
LB730 - Analysis of Glutathione -

LC InertSearch InertSustain AX-C18
LB729 - Analysis of L-Cystine and L-Cysteine and L-Cysteic acid -

LC InertSearch InertSustain AX-C18
LB722 - Analysis of Ethenzamide -

LC InertSearch InertSustain C18
LB721 - Analysis of Acetaminophen -

LC InertSearch InertSustain C18
LB720 - Analysis of Acetylsalicilic acid -

LC InertSearch InertSustain C18
GA342 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 B) -

GC InertSearch InertCap WAX
GA341 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 A) -

GC InertSearch InertCap WAX
GA340 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 1) -

GC InertSearch InertCap WAX
GA339 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 B) -

GC InertSearch InertCap 624MS
GA338 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 A) -

GC InertSearch InertCap 624MS
GA337 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 1) -

GC InertSearch InertCap 624MS
LB702 - Analysis of ibuprofen -

LC InertSearch InertSustain C18
LB701 - Analysis of chlorpheniramine maleate -

LC InertSearch Inertsil ODS-4
LB700 - Analysis of acetaminophen -

LC InertSearch InertSustain C18
LB699 - Analysis of Refined Glucose (Japanese Pharmacopoeia 18th Edition, Glucose, Assay) -

LC InertSearch InertSphere Sugar-2
LB698 - Analysis of Neomycin Sulfate (European Pharmacopoeia 11.0th Edition, Purity Test) -

LC InertSearch InertSustain C18
LB692 - Analysis of Nitrosamines -

LC InertSearch InertSustain AQ-C18
LB691 - Analysis of Nitrosamines -

LC InertSearch InertSustain PFP
GA333 - Residual solvents in pharmaceuticals (JP 18 Standard stock solution Class 2 C) -

GC InertSearch InertCap WAX
GA332 - Residual solvents in pharmaceuticals (JP 18 Standard stock solution Class 2 C) -

GC InertSearch InertCap 624MS
GA331 - Residual solvents in pharmaceuticals (JP 18 Standard stock solution Class 2 C) -

GC InertSearch InertCap 624MS
GA330 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 B) -

GC InertSearch InertCap WAX
GA329 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 B) -

GC InertSearch InertCap 624MS
GA328 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 B) -

GC InertSearch InertCap 624MS
GA327 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 A) -

GC InertSearch InertCap WAX
GA326 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 A) -

GC InertSearch InertCap 624MS
GA325 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 A) -

GC InertSearch InertCap 624MS
GA324 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 1) -

GC InertSearch InertCap WAX
GA323 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 1) -

GC InertSearch InertCap 624MS
GA322 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 1) -

GC InertSearch InertCap 624MS
LB690 - Analysis of Nitrosamines -

LC InertSearch InertSustain PFP
GA319 - Residual solvents in pharmaceuticals (Class 3) -

GC InertSearch InertCap Pure-WAX
GA318 - Residual solvents in pharmaceuticals (Class 3) -

GC InertSearch InertCap 624MS
LT051 - Analysis of Allantoin in Cosmetics Using HILIC HPLC -

LC Technical Note Inertsil HILIC
LB564 - Analysis of Steviol glycosides (Under the Condition of the JPE (Japanese Pharmaceutical Excipients), Purified Stevia Extract Assay) -

LC InertSearch Inertsil NH2
LB563 - Analysis of Steviol (Under the Condition of the JPE (Japanese Pharmaceutical Excipients), Purified Stevia Extract (4) Steviol) -

LC InertSearch InertSustain AQ-C18
LB562 - Analysis of Steviol (Under the Condition of the JPE (Japanese Pharmaceutical Excipients), Purified Stevia Extract (4) Steviol) -

LC InertSearch Inertsil ODS-HL
LB542 - Analysis of D-Mannitol (Under the Condition of the JPE (Japanese Pharmaceutical Excipients), D-Mannitol and Corn starch compound) -

LC InertSearch InertSphere Sugar-2
LB312 - Analysis of Acesulfame potassium (InertSustain C18) (Under the Condition of the JPE (Japanese Pharmaceutical Excipients)) -

LC InertSearch InertSustain C18
LB311 - Analysis of Acesulfame potassium (Inertsil ODS-3) (Under the Condition of the JPE (Japanese Pharmaceutical Excipients)) -

LC InertSearch Inertsil ODS-3
LB228 - Analysis of Polyvinyl alcohol, Polyethyleneglycol and Graft copolymer (Under the Condition of the JPE (Japanese Pharmaceutical Excipients), (3) Acetic acid) -

LC InertSearch InertSustain C18
LB224 - Analysis of Tocopherol (InertSuatin C18) (Under the Condition of the Japanese Pharmaceutical Codex) -

LC InertSearch InertSustain C18
GT115 - Purity Test of Sucralose, Pharmaceutical Excipients Standard 2018 -

GC Technical Note InertCap 624MS
GT036 - Analysis of Residual Solvent Components in Pharmaceutical Products - Using InertCap 5 -

GC Technical Note InertCap 5
GT035 - Analysis of Residual Solvent Components in Drugs - Using InertCap 624 -

GC Technical Note InertCap 624
GT023 - Analysis of Residual Solvent Components in Pharmaceutical Products ? Using InertCap Pure-WAX -

GC Technical Note InertCap Pure-WAX
GA288 - Residual solvents in pharmaceuticals (Class 2B) -

GC InertSearch InertCap 624MS
GA287 - Residual solvents in pharmaceuticals (Class 2A) -

GC InertSearch InertCap 624MS
GA286 - Residual solvents in pharmaceuticals (Class 1) -

GC InertSearch InertCap 624MS
GA281 - Residual solvents in pharmaceuticals -

GC InertSearch InertCap WAX
GA153 - Ethanolamines -

GC InertSearch InertCap for Amines
GA128 - Residual solvents in pharmaceuticals -

GC InertSearch InertCap 5
GA127 - Residual solvents in pharmaceuticals Class3 -

GC InertSearch InertCap 5
GA126 - Residual solvents in pharmaceuticals Class2 -

GC InertSearch InertCap 5
GA125 - Residual solvents in pharmaceuticals Class1 -

GC InertSearch InertCap 5
GA124 - Residual solvents in pharmaceuticals -

GC InertSearch InertCap 5
GA123 - Residual solvents in pharmaceuticals -

GC InertSearch InertCap 624
GA094 - Residual solvents in pharmaceuticals Class3 -

GC InertSearch InertCap Pure-WAX
GA093 - Residual solvents in pharmaceuticals Class3 -

GC InertSearch InertCap 624
GA092 - Residual solvents in pharmaceuticals Class2 -

GC InertSearch InertCap Pure-WAX
GA091 - Residual solvents in pharmaceuticals Class2 -

GC InertSearch InertCap 624
GA090 - Residual solvents in pharmaceuticals Class1 -

GC InertSearch InertCap Pure-WAX
GA089 - Residual solvents in pharmaceuticals Class1 -

GC InertSearch InertCap 624

Applications including "pharmaceutical"

LT201 - Analysis of nitrosoamines by LC-MS / MS, HPLC using InertSustain AQ-C18 -Comparison with PFP column- -

GA113 - Residual solvents in pharmaceuticals -

LB902 - Analysis of Saxagliptin -

LB901 - Analysis of Saxagliptin -

LB900 - Analysis of Fesoterodine Fumarate -

LB899 - Analysis of Fesoterodine Fumarate -

GA351 - Analysis of Dextran 40 -

GA350 - Analysis of Acrylic Acid and Methyl Methacrylate -

LB896 - Analysis of Triptorelin Pamoate -

LB895 - Analysis of Venlafaxine hydrochloride -

LB894 - Analysis of Ursodiol -

LB891 - Analysis of Saxagliptin -

LB890 - Analysis of Saxagliptin -

LB889 - Analysis of Propyl gallate -

LB888 - Analysis of Propyl gallate -

LB887 - Analysis of Propyl gallate -

LB885 - Analysis of Voriconazole -

LB884 - Analysis of Voriconazole -

LB883 - Analysis of Paclitaxel -

LB882 - Analysis of Paracetamol and Mefenamic acid -

LB881 - Analysis of Paracetamol and Mefenamic acid -

LB880 - Analysis of Paracetamol and Mefenamic acid -

LB879 - Analysis of Paracetamol and Mefenamic acid -

LB878 - Analysis of Mefenamic acid -

LB877 - Analysis of Mefenamic acid -

LB876 - Analysis of Cefoxitin -

LB875 - Analysis of Levofloxacin -

LB874 - Analysis of Captopril and Captopril Disulfide -

LB873 - Tacrolimus Extended-Release Capsules -

LB872 - Analysis of Febuxostat -

LB871 - Analysis of Febuxostat -

LB870 - Analysis of Febuxostat -

LB867 - Analysis of Febuxostat -

LB849 - Analysis of Tolvaptan (Under the Condition of the draft for the Japanese Pharmacopoeia 18th SupplementII) -

LB848 - Analysis of Tolvaptan (Under the Condition of the draft for the Japanese Pharmacopoeia 18th SupplementII) -

LB837 - Analysis of Nonsteroidal anti-inflammatory drug -

LB827 - Analysis of Clobetasone butyrate standard -

LB823 - Analysis of Glycyrrhiza -

LB816 - Analysis of Zoledronic acid -

LB815 - Analysis of Riboflavin (Vitamin B2) and its metabolites -

LB814 - Analysis of Coenzyme A (CoA) -

LB806 - Analysis of Ampicillin and Sulbactam (Under the Condition of the Japanese Pharmacopoeia 18th , Ampicillin Sodium and Sulbactam Sodium for Injection) -

LB804 - Analysis of Metformin -

LB803 - Simultaneous analysis of Amino acids derivatized with 4-fluoro-7-nitro-2,1,3-benzoxadiazole (NBD-F) -

LB789 - Analysis of Oligonucleotides -

LB788 - Analysis of Oligonucleotides -

LB787 - Analysis of Oligonucleotides -

LB786 - Analysis of Oligonucleotides -

LB779 - Analysis of Coenzyme A (CoA) -

LB778 - Analysis of Coenzyme A (CoA) -

LB773 - Analysis of Nicotinamide adenine dinucleotide and Nicotinamide adenine dinucleotide phosphate (NAD+, NADH, NADP+, NADPH) -

LB772 - Analysis of Nicotinamide adenine dinucleotide (NADH, NAD+) -

LB771 - Analysis of Nucleoside and Nucleic acid base -

LB769 - Analysis of Thiamine and Thiamine pyrophosphate -

LB768 - Analysis of Low molecular weight Hyaluronic acid -

LB767 - Analysis of Chondroitin Sulfate -

LB762 - Analysis of L-Cysteic acid -

LB761 - Analysis of Doripenem (Under the Condition of the Japanese Pharmacopoeia 18th, Doripenem Hydrate) -

LB760 - Analysis of Doripenem (Under the Condition of the Japanese Pharmacopoeia 18th, Doripenem Hydrate) -

LB759 - Analysis of Doripenem (Under the Condition of the Japanese Pharmacopoeia 18th, Doripenem Hydrate) -

LB758 - Analysis of Doripenem (Under the Condition of the Japanese Pharmacopoeia 18th, Doripenem Hydrate) -

LB757 - Analysis of Fenofibrate (Under the Condition of the Japanese Pharmacopoeia 18th) -

LB756 - Analysis of Fenofibrate (Under the Condition of the Japanese Pharmacopoeia 18th) -

LB755 - Analysis of Oxaliplatin (Under the Condition of the draft for the Japanese Pharmacopoeia18th supplement II) -

LB754 - Analysis of Saccharin (Under the Condition of the Japanese Pharmacopoeia 18th, Saccharin Sodium Hydrate) -

LB740 - Analysis of Acetaminophen -

LB739 - Analysis of Acetaminophen -

LB738 - Analysis of Remdesivir -

LB737 - Analysis of Favipiravir -

LB736 - Analysis of Antidepressants -

LB735 - Analysis of Antihistamines -

LB733 - Analysis of Water-soluble Vitamins -

LB730 - Analysis of Glutathione -

LB729 - Analysis of L-Cystine and L-Cysteine and L-Cysteic acid -

LB722 - Analysis of Ethenzamide -

LB721 - Analysis of Acetaminophen -

LB720 - Analysis of Acetylsalicilic acid -

GA342 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 B) -

GA341 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 A) -